Tower Research Capital (TRC)’s Summit Healthcare Acquisition Corp. Class A Ordinary Share SMIH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-8
Closed 6648
2022
Q4
$0 Buy
+8
New +$80 ﹤0.01% 6710

Tower Research Capital (TRC)'s SMIH Position: Q1 2023 in Review

Tower Research Capital (TRC) sold out of Summit Healthcare Acquisition Corp. Class A Ordinary Share (SMIH) in Q1 2023, closing a stake of 8 shares.

Tower Research Capital (TRC) first reported a position in SMIH in Q4 2022 and held it in 1 quarter. The position peaked at $0 in Q4 2022. 0 funds tracked by Wall St. Rank hold SMIH as of Q1 2023.

  • Tower Research Capital (TRC) reported no remaining Summit Healthcare Acquisition Corp. Class A Ordinary Share position as of Q1 2023 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 8 Summit Healthcare Acquisition Corp. Class A Ordinary Share shares in Q1 2023.
  • Tower Research Capital (TRC) first reported a position in Summit Healthcare Acquisition Corp. Class A Ordinary Share in Q4 2022 and held it in 1 quarter.
  • Tower Research Capital (TRC)'s Summit Healthcare Acquisition Corp. Class A Ordinary Share position peaked at $0 in Q4 2022.
  • 0 funds tracked by Wall St. Rank held Summit Healthcare Acquisition Corp. Class A Ordinary Share as of Q1 2023.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.